logo
WeightWatchers to focus on menopause after fat jabs cripple business

WeightWatchers to focus on menopause after fat jabs cripple business

Telegraph2 days ago
WeightWatchers is to launch a new menopause programme as appetite-suppressing fat jabs put pressure on its dieting business.
The New York-headquartered company said it will support women through mid-life hormonal changes with a programme of tailored nutritional help and advice on lifestyle changes.
The strategic shift comes after WeightWatchers filed for bankruptcy in May, allowing it to write off $1.15bn (£810m) in debt from its balance sheet.
WeightWatchers said its expansion into women's health would 'address a broader gap in healthcare' adding it had been 'long underserved and overlooked by scientific and medical communities'. Tara Comonte, chief executive of WeightWatchers, labelled the transformation a 'pivotal moment' for the company.
Dieting businesses like WeightWatchers are scrambling to adapt to the rapidly growing market for weight-loss drugs. Morgan Stanley has predicted that the market could hit $105bn (£81.3bn) by 2030.
WeightWatchers suffered a blow in 2023 when long-time brand ambassador and board member Oprah Winfrey announced that she was using an unspecified weight loss medication in 2023. Ms Winfrey then left the company's board the following year.
Last week, Wes Streeting, the health secretary, told LBC Radio that weight-loss drugs were the ' talk of the House of Commons tea rooms ' and claimed half of his colleagues were using them.
Mr Streeting pledged to widen public access to weight-loss drugs, stating that they should be 'based on need and not the ability to pay'.
Weight-loss jabs make users feel fuller for longer by slowing the speed at which their stomachs empty. This is a significant challenger for WeightWatchers, which markets a willpower-based alternative to shedding pounds.
In a move to adapt, WeightWatchers announced in May that its UK subsidiary had partnered with CheqUp, a provider of weight-loss jabs. The company also redesigned its app to target people on weight-loss injections, offering food recommendations to minimise the side-effects of the jabs, such as nausea.
WeightWatchers said its new women's health programme would support people through perimenopause, menopause and postmenopause. It added that it would provide nutritional guidance and specialised coaching for women at this stage in their life.
Founded in 1963 by the American businesswoman Jean Nidetch, the company helps users monitor their diets by attributing scores to different foods. WeightWatchers also sells its own range of ready meals and low-calorie wines.
It is not the only company facing challenges as a result of weight loss jabs. Glanbia, the owner of meal replacement company SlimFast, recently announced it would sell the business in February following a decline in sales.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US aid cuts: South Africa's HIV/Aids patients worry about treatment
US aid cuts: South Africa's HIV/Aids patients worry about treatment

BBC News

time36 minutes ago

  • BBC News

US aid cuts: South Africa's HIV/Aids patients worry about treatment

Gugu used to collect her anti-retroviral from a USAID-funded clinic in downtown when President Trump's cuts to aid funding were announced earlier this year, her and thousands of other HIV-positive patients across South Africa suddenly faced an uncertain was lucky, the clinic where she got the medication that helps suppress her symptoms contacted her before it closed down."I was one of the people who was able to get their medication in bulk. I usually collect a three-month prescription. But before my clinic closed, they gave me nine months' worth of medication."She will run out of ARVs in September, and then plans on going to her local public hospital for more.A former sex worker, the 54-year-old found out she was HIV-positive after she'd quit the years ago she got a chesty cough, and initially thought it was tuberculosis. She went to a doctor who told her she had a chest infection and treated her for when the treatment failed, she went to a clinic to get an HIV test."By then I already assumed that I was HIV-positive, and I told the nurse this."She was right, and she has been on antiretrovirals (ARVs) ever since. We're not using her real name at her currently works as a project coordinator for an NGO."We help pregnant sex workers get their ARVs, to ensure their children are born HIV-negative. We also do home visits to make sure that the mothers take their medication on time, and to look after their babies when they go for their monthly check-ups."Many HIV-positive sex workers in South Africa relied on private clinics funded by the US government's now-defunct aid agency, USAID, to get their prescriptions and most of the facilities closed after US President Donald Trump cut most foreign aid earlier this a report due to be released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that drastic cuts from a number of donors have sent shockwaves around the world, and the "phenomenal progress" in tackling the illness risks being reversed."New HIV infections have been reduced by 40% since 2010, and 4.4 million children have been protected from acquiring HIV since 2000. More than 26 million lives have been saved," UNAIDS says, warning that if the world does not act, there could be an extra six million new HIV infections and four million AIDS-related deaths by has so far been lucky. The clinic from where she got her antiretrovirals in Johannesburg contacted her before it closed. She will run out of antiretrovirals in September, and will then go to her local public hospital for believes that many sex workers could be discouraged from doing so."The problem with going to public hospitals is the time factor. In order to get serviced at these facilities, you have to arrive at 4 or 5am, and they may spend the whole day waiting for their medication. For sex workers, time is money," Gugu adds that she recently went to her local clinic with some friends to register her details and build a relationship with staff."The nurse who attended to us was very rude. She told us there was nothing special about sex workers."She thinks this could lead to many sex workers defaulting on their medication, "especially because their hospital files contain a lot of personal information, and the concern is that sometimes the nurses at these local clinics aren't always the most sensitive in dealing with this kind of information."According to the UN, the US cuts to HIV funding could reverse some of the gains made by what has been called one of the most successful public health interventions in in the UK-based Lancet medical journal last month estimated that USAID funding directly reduced Aids deaths by 65%, or 25.5 million, over the past two decades. Then-US President George W Bush launched an ambitious programme to combat HIV/Aids in 2003, saying it would serve the "strategic and moral interests" of the as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the global HIV/Aids response - the largest commitment by any nation to address a single disease in the Africa has about 7.7 million people living with HIV, the highest number in the world, according to 5.9 million of them receive antiretroviral treatment, resulting in a 66% decrease in Aids-related deaths since 2010, the UN agency Africa's government says Pepfar funding contributed about 17% to its HIV/Aids programme. The money was used for various projects, including running mobile clinics to make it easier for patients to get Trump administration's cuts have raised concern that infection rates could spike again. "I think we're going to start seeing an increase in the number of HIV infections, the number of TB cases, the number of other infectious diseases," Prof Lynn Morris, Deputy Vice-Chancellor of Johannesburg's Wits University, tells the BBC."And we're going to start seeing a reversal of what was essentially a real success story. We were getting on top of some of these things."Gugu points out that treatment is a matter of life and death, especially for vulnerable populations like sex workers."People don't want to default on their ARVs. They're scared that they're going to die if they don't get access to cuts have also affected research aimed at finding an HIV vaccine and a cure for Aids."There's the long-term impact, which is that we're not going to be getting new vaccines for HIV," Prof Morris adds. "We're not going to be keeping on top of viruses that are circulating. Even with new viruses that might appear, we're not going to have the surveillance infrastructure that we once had."South Africa has been one of the global leaders in HIV research. Many of the medications that help prevent the virus, and which have benefitted people around the world, were trialled in South includes Prep (pre-exposure prophylaxis), a medication which stops HIV-negative people from catching the breakthrough preventive drug released this year, Lenacapavir, an injection taken twice a year and that offers total protection from HIV, was also tried in South Africa. In a lab at Wits University's Health Sciences campus, a small group of scientists are still working on a vaccine for HIV. They are part of the Brilliant Consortium, a group of labs working across eight African countries to develop a vaccine for the virus."We were developing a vaccine test to see how well that works, and then we would trial it on humans," Abdullah Ely, an Associate Professor at Wits University, tells the BBC in his lab. "The plan was to run the trials in Africa based on research carried out by Africans because we want that research to actually benefit our community as well as all mankind."But the US funding cuts threw their work into doubt. "When the stop order came, it meant we had to stop everything. Only some of us have been able to get additional funding so we could continue our work. It's set us back months, probably could even be a year," Prof Ely lab lacks funding to carry out clinical trials scheduled for later this year."That is a very big loss to South Africa and the continent. It means that any potential research that comes out of Africa will have to be tested in Europe, or the US," Prof Ely says. In June, universities asked the government for a bailout of 4.6bn South African rand ($260m; £190m) over the next three years to cover some of the funding lost from the US. "We are pleading for support because South Africa is leading in HIV research, but it's not leading for itself. This has ramifications on the practice and policies of the entire globe," says Dr Phethiwe Matutu, head of Universities South Africa. South Africa's Health Minister Aaron Motsoaledi announced on Wednesday that some alternative funding for research had been secured. The Bill and Melinda Gates Foundation and the Wellcome Trust have agreed to donate 1m rand each with immediate effect, while the government would make available 400m rand over the next three years, he said. This would bring the total to 600m rand, way below the 4.6bn rand requested by for Gugu, she had hoped that by the time she was elderly, a cure for HIV/Aids would have been found, but she is less optimistic now."I look after a nine-year-old. I want to live as long as I can to keep taking care of him," she tells the BBC. "This isn't just a problem for right now, we have to think about how it's going to affect the next generation of women and young people." You may also be interested in: 'My wife fears sex, I fear death' - impacts of the USAID freeze'People will starve' because of US aid cut to SudanWhat is USAID and why is Trump closing it down? Go to for more news from the African us on Twitter @BBCAfrica, on Facebook at BBC Africa or on Instagram at bbcafrica

South Korea, car makers seek relief from US port fees on vehicle carriers
South Korea, car makers seek relief from US port fees on vehicle carriers

Reuters

timean hour ago

  • Reuters

South Korea, car makers seek relief from US port fees on vehicle carriers

Seoul, July 7 (Reuters) - South Korea and the country's auto association requested on Monday relief from a U.S. plan to levy port fees on all foreign-built vehicle carriers, saying it would add a significant burden to a car industry that has pledged big investments in the United States. The U.S. Trade Representative announced the fees on April 17 as part of an ongoing effort to penalise some China-linked ships calling at U.S. ports with fees to fund a domestic shipbuilding revival and counter China's dominance on the high seas. The fees have sent shockwaves though the vehicle carrier industry, because they go beyond targeting Chinese-built and Chinese-owned ships. The Korea Automobile & Mobility Association, which represents Hyundai Motor ( opens new tab, Kia ( opens new tab and the South Korean units of General Motors (GM.N), opens new tab and Renault ( opens new tab, also raised concerns that the fees would impose "additional financial burdens on imported automobiles that are already subject to 25% tariffs," according to its comments submitted to the USTR. "Such a measure risks imposing undue costs on companies, workers and consumers in both countries," South Korea's trade ministry and maritime ministry said in separate comments. The auto association also highlighted Hyundai Motor Group's $21 billion investment plan announced by its chairman and U.S. President Donald Trump at the White House in March. The rule "may in turn adversely impact the contributions that Korean firms are making to U.S. commerce," it said.

Gold edges higher on softer dollar, trade war intensifies
Gold edges higher on softer dollar, trade war intensifies

Reuters

timean hour ago

  • Reuters

Gold edges higher on softer dollar, trade war intensifies

July 10 (Reuters) - Gold prices edged higher on Thursday, helped by a slight retreat in the dollar and bond yields, while investors kept a close tab on trade negotiations as U.S. President Donald Trump broadened his tariff war. Spot gold rose 0.3% to $3,322.46 per ounce by 0157 GMT. U.S. gold futures were up 0.3% at $3,331. Trump launched his global tariff assault into overdrive on Wednesday, announcing a new 50% tariff on U.S. copper imports and a 50% duty on goods from Brazil, both to start on August 1. Trump also issued tariff notices for seven minor trading partners on Thursday, adding to 14 others issued earlier in the week, including South Korea and Japan, with 25% levies set to take effect on August 1 unless agreements are reached. Meanwhile, Trump said trade talks have been going well with China and the European Union, which is the biggest bilateral trading partner of the U.S. "The market impact of tariffs seems to lessen with each new headline. Tariff fatigue is here, and traders need a new catalyst to awaken volatility from its lull," said Matt Simpson, a senior analyst at City Index. The U.S. dollar index (.DXY), opens new tab edged down 0.3%, while the yield on benchmark 10-year U.S. Treasury notes retreated from a three-week high. Lower yields reduce the opportunity cost of holding non-yielding bullion, while a weaker dollar makes gold cheaper for holders of other currencies. Minutes of the Federal Reserve's June 17-18 meeting showed that only "a couple" of Fed officials believed interest rate cuts could happen as early as this month, with most favouring reductions later this year due to inflation concerns tied to Trump's tariff policies. The Federal Open Market Committee unanimously voted to hold rates steady at its June meeting, with the next policy meeting scheduled for July 29-30. Spot silver edged up 0.2% to $36.41 per ounce, platinum fell 0.3% to $1,343.22 and palladium inched up 0.1% to $1,106.25.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store